Contact
Please use this form to send email to PR contact of this press release:
Bavarian Nordic Announces Positive Results of Pivotal Phase 3 Study of IMVAMUNE® Smallpox Vaccine
TO:
Please use this form to send email to PR contact of this press release:
Bavarian Nordic Announces Positive Results of Pivotal Phase 3 Study of IMVAMUNE® Smallpox Vaccine
TO: